Skip to Main Content

Paper Details

Prescribing cholinesterase inhibitors in mild cognitive impairment-Observations from the Alzheimer's Disease Neuroimaging Initiative.
Alzheimers Dement (N Y)
6
2021
AChEI, AChEI+, ADNI, Alzheimer's Disease, FDG, MCI, acetylcholinesterase, amyloid, atrophy, cholinesterase, fluorodeoxyglucose, mild cognitive impairment, neurodegeneration, participants
Author NameAffiliation
Shannon L Risacher
Shannon L RisacherDepartment of Radiology and Imaging Sciences IU School of Medicine Indianapolis IN USA.
Jerome I RotterThe Institute for Translational Genomics and Population Sciences Harbor-university of california los angeles Medical Center Torrance CA USA.
Jerome I RotterThe Lundquist Institute for Biomedical Innovation Harbor-university of california los angeles Medical Center Torrance CA USA.
Jerome I RotterDepartment of Pediatrics Harbor-university of california los angeles Medical Center Torrance CA USA.
Andrew J Saykin
Andrew J SaykinDepartment of Radiology and Imaging Sciences IU School of Medicine Indianapolis IN USA.
Andrew J Saykin
Andrew J SaykinDepartment of Radiology and Imaging Sciences IU School of Medicine Indianapolis IN USA.
Liana G Apostolova
Liana G ApostolovaDepartment of Neurology IU School of Medicine Indianapolis IN USA.
Liana G ApostolovaDepartment of Radiology and Imaging Sciences IU School of Medicine Indianapolis IN USA.
Liana G ApostolovaDepartment of Medical and Molecular Genetics IU School of Medicine Indianapolis IN USA.
  • 1 - 13

Datasets

Release 1.2